INIS
cancer
100%
patients
88%
colombia
82%
risks
81%
breasts
81%
genes
79%
diseases
60%
genetics
52%
populations
42%
mutations
42%
children
40%
birth
37%
congenital diseases
36%
control
36%
humans
34%
defects
30%
receptors
30%
levels
29%
data
27%
proteins
22%
surveillance
21%
phenotype
20%
mortality
20%
reviews
20%
blood
19%
women
17%
tissues
16%
newborns
16%
immunity
15%
hospitals
15%
vaccines
15%
ovaries
15%
viruses
15%
estrogens
14%
congenital malformations
14%
lungs
14%
screening
14%
hearings
14%
malformations
14%
comparative evaluations
14%
pregnancy
13%
losses
13%
information
13%
dna
13%
cytokines
12%
adults
12%
tumors
12%
antibodies
12%
protection
12%
spectra
11%
variations
11%
mapping
10%
pediatrics
10%
sex
10%
death
9%
dendrites
9%
carriers
9%
plasma
9%
infants
9%
etiology
9%
cities
9%
diarrhea
9%
management
8%
south america
8%
symptoms
8%
males
8%
immunoglobulins
8%
females
8%
nervous system diseases
8%
exons
8%
developing countries
7%
inflammation
7%
correlations
7%
regulations
7%
mice
7%
alcohols
7%
rna
7%
in vitro
7%
placenta
7%
chromosomes
7%
nucleotides
7%
assessments
6%
distribution
6%
public health
6%
detection
6%
origin
6%
interactions
6%
mitochondria
6%
prediction
6%
corrections
6%
promoters
6%
skin
6%
therapy
6%
interleukins
6%
apoptosis
6%
lupus
6%
evaluation
6%
lymphocytes
6%
antigens
6%
implementation
5%
Medicine and Dentistry
Prevalence
35%
Congenital Malformation
33%
Breast Cancer
30%
Diseases
17%
Rotavirus
15%
Neonatal Infant
15%
Cancer Risk
15%
Infection
14%
BRCA1
13%
Odds Ratio
10%
Congenital Disorder
10%
Case-Control Study
10%
Hearing Impairment
8%
Ovarian Cancer
8%
BRCA2
8%
Diagnosis
7%
Pre-Eclampsia
7%
Disorders of Sex Development
7%
Central Nervous System
6%
Estrogen Receptor
6%
Health Care
6%
Estrogen Receptor Negative Breast Cancer
5%
Hypospadias
5%
Single Nucleotide Polymorphism
5%
Placenta
5%
T Cell
5%
B Cell
5%
Malignant Neoplasm
5%
Neoplasm
5%
Folic Acid
5%